Lymphoma, Mixed-Cell

Also known as: Mixed-cell type lymphoma / Mixed-Cell Lymphoma

Drug	Drug Name	Drug Description
DB00531	Cyclophosphamide	A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma.

Drug	Drug Name	Target	Type
DB00531	Cyclophosphamide	DNA	target
DB00531	Cyclophosphamide	Cytochrome P450 2B6	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2C9	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 3A4	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2C19	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2A6	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2C18	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2C8	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 3A5	enzyme
DB00531	Cyclophosphamide	Nuclear receptor subfamily 1 group I member 2	target

Drug	Drug Name	Phase	Status	Count
DB05656	Veltuzumab	1 / 2	Completed	1